Vivo is all set to enter the pill section within the first half of 2022. This was first talked about by Vivo’s Government Vice President Hu Baishan throughout an interview in August. The corporate had additionally trademarked “Vivo Pad” with the European Union Mental Property Workplace (EUIPO) in June beneath Class 9, which covers, amongst many merchandise, tablets and PDAs. Whereas we anticipate an official replace from Vivo, a identified tipster has claimed that Vivo is anticipated to launch a pill with a Qualcomm Snapdragon chipset.
Tipster Digital Chat Station has posted on Weibo that Vivo might be launching a pill with a Snapdragon 870 SoC. A Vivo system that was noticed on TÜV Rheinland certification web site just lately is alleged to be this upcoming pill. It means that the aforementioned system goes to be geared up with an 8,040mAh battery.
Different main smartphone producers are additionally tipped to enter the pill market, together with Oppo and OnePlus.
The title “OnePlus Pad” was trademarked with the EUIPO in July. Moreover, a just lately surfaced picture is believed to supply extra particulars concerning the rumoured Oppo pill. In response to Digital Chat Station, the Oppo pill might be powered by a Snapdragon 870 SoC paired with 6GB of RAM and 256GB of storage. It’s stated to run on the Android 11-based ColorOS 12 and options an 8,080mAh battery. The pill is alleged to have an 11-inch LCD display with a 120Hz refresh fee and a decision of two,560×1,600 pixels. Moreover, the tipster claims that the pill might be geared up with a 13-megapixel main digital camera and an 8-megapixel entrance shooter.
Whereas its sister manufacturers are nonetheless competing to enter the section, Realme was the primary BBK Electronics model to have launched its pill in September this yr. Realme Pad encompasses a MediaTek Helio G80 chip with 4GB of RAM and 64GB of Storage. It has 8-megapixel cameras on the entrance and the again. Additionally, the pill is fitted with a 7,100mAh battery.